Tower Research Capital (TRC)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
4,468
-11,914
-73% -$892K 0.01% 1271
2025
Q4
$1.29M Buy
16,382
+8,716
+114% +$690K 0.03% 451
2025
Q3
$631K Sell
7,666
-9,655
-56% -$760K 0.02% 720
2025
Q2
$1.39M Sell
17,321
-4,234
-20% -$327K 0.04% 422
2025
Q1
$1.73M Sell
21,555
-26,509
-55% -$2.2M 0.05% 323
2024
Q4
$3.94M Buy
48,064
+27,754
+137% +$2.31M 0.08% 193
2024
Q3
$1.68M Sell
20,310
-54,451
-73% -$4.07M 0.04% 340
2024
Q2
$5.25M Buy
74,761
+58,287
+354% +$4.16M 0.09% 183
2024
Q1
$1.22M Sell
16,474
-73,972
-82% -$5.16M 0.03% 439
2023
Q4
$5.98M Buy
90,446
+46,127
+104% +$2.89M 0.07% 224
2023
Q3
$2.79M Buy
44,319
+37,922
+593% +$2.36M 0.09% 216
2023
Q2
$362K Sell
6,397
-12,642
-66% -$702K 0.01% 1187
2023
Q1
$1.1M Buy
19,039
+4,396
+30% +$297K 0.04% 394
2022
Q4
$1.06M Sell
14,643
-49,556
-77% -$3.55M 0.04% 357
2022
Q3
$3.9M Buy
64,199
+8,454
+15% +$540K 0.06% 241
2022
Q2
$3.5M Sell
55,745
-67,289
-55% -$4.45M 0.08% 210
2022
Q1
$8.65M Buy
123,034
+60,617
+97% +$4.1M 0.08% 211
2021
Q4
$3.9M Buy
62,417
+53,943
+637% +$3.39M 0.07% 247
2021
Q3
$523K Sell
8,474
-2,495
-23% -$150K 0.01% 952
2021
Q2
$657K Sell
10,969
-79,903
-88% -$5.06M 0.02% 961
2021
Q1
$5.52M Buy
90,872
+60,786
+202% +$3.35M 0.09% 193
2020
Q4
$1.41M Buy
30,086
+12,304
+69% +$533K 0.04% 348
2020
Q3
$661K Buy
17,782
+2,055
+13% +$78K 0.01% 1374
2020
Q2
$574K Buy
15,727
+7,515
+92% +$262K 0.02% 906
2020
Q1
$251K Buy
+8,212
New +$364K 0.02% 658
2019
Q4
Sell
-19,424
Closed -$916K 4045
2019
Q3
$916K Buy
19,424
+17,330
+828% +$826K 0.06% 316
2019
Q2
$104K Sell
2,094
-14,630
-87% -$688K 0.01% 1157
2019
Q1
$712K Sell
16,724
-663
-4% -$29.3K 0.04% 410
2018
Q4
$714K Buy
17,387
+7,296
+72% +$313K 0.05% 333
2018
Q3
$471K Sell
10,091
-45,855
-82% -$2.1M 0.03% 508
2018
Q2
$2.44M Buy
55,946
+36,982
+195% +$1.72M 0.14% 137
2018
Q1
$870K Sell
18,964
-578
-3% -$28K 0.07% 236
2017
Q4
$988K Buy
19,542
+19,501
+47,563% +$1.03M 0.13% 165
2017
Q3
$2K Sell
41
-8,621
-100% -$420K ﹤0.01% 3571
2017
Q2
$425K Buy
8,662
+5,844
+207% +$271K 0.05% 237
2017
Q1
$133K Sell
2,818
-40,947
-94% -$1.95M 0.01% 392
2016
Q4
$2.1M Buy
43,765
+36,470
+500% +$1.67M 0.23% 102
2016
Q3
$289K Sell
7,295
-23,977
-77% -$901K 0.03% 335
2016
Q2
$1.11M Buy
31,272
+29,571
+1,738% +$1.15M 0.11% 142
2016
Q1
$67K Buy
+1,701
New +$63.6K 0.01% 641
2015
Q4
Sell
-751
Closed -$32K 4813
2015
Q3
$32K Buy
751
+86
+13% +$4.02K ﹤0.01% 1340
2015
Q2
$33K Buy
665
+438
+193% +$20.7K ﹤0.01% 1682
2015
Q1
$10K Sell
227
-2,670
-92% -$120K ﹤0.01% 2795
2014
Q4
$140K Sell
2,897
-23,866
-89% -$1.13M 0.01% 443
2014
Q3
$1.28M Buy
26,763
+26,590
+15,370% +$1.29M 0.14% 130
2014
Q2
$9K Sell
173
-21,226
-99% -$993K ﹤0.01% 2442
2014
Q1
$1.01M Buy
21,399
+20,789
+3,408% +$955K 0.13% 125
2013
Q4
$29K Sell
610
-47,005
-99% -$2.11M ﹤0.01% 1925
2013
Q3
$1.99M Buy
47,615
+46,000
+2,848% +$1.98M 0.21% 96
2013
Q2
$66K Buy
+1,615
New +$59.4K 0.01% 754

Other funds holding MET

Tower Research Capital (TRC)'s MET Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its MetLife (MET) stake by 73% in Q1 2026, selling an estimated $892K and leaving 4,468 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #1271.

Tower Research Capital (TRC) first reported a position in MET in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.65M in Q1 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Tower Research Capital (TRC) held 4,468 shares of MetLife worth $316K as of Q1 2026.
  • Tower Research Capital (TRC) sold 11,914 MetLife shares in Q1 2026, an estimated $892K.
  • MetLife made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1271 holding.
  • Tower Research Capital (TRC) first reported a position in MetLife in Q2 2013 and has held it in 50 quarters since.
  • Tower Research Capital (TRC)'s MetLife position peaked at $8.65M in Q1 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.